Independent physician practices more resilient during COVID-19, study finds

Large health systems are acquiring smaller physician practices at what some consider an alarming rate, leaving fewer independent practices.

Catalent’s Indiana site closes out three Form 483s in past two years

One of Catalent’s three sites at the center of the Novo-Catalent deal has been hit by at least three form 483s in the past two

February 9, 2024

Global life expectancy to rise by nearly 5 years by 2050, GBD 2021 study predicts

The latest findings from the Global Burden of Disease Study (GBD) 2021, published today in The Lancet, forecast that global life expectancy will increase by

May 17, 2024

Risk adjusted net present value: What is the current valuation of Kissei Pharmaceutical’s Cretostimogene Grenadenorepvec?

Cretostimogene Grenadenorepvec is an oncolytic virus commercialized by Kissei Pharmaceutical, with a leading Phase III program in Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.